You are here

  • Home
  • Archive
  • Volume 73, Issue 3
  • Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

Article info

Article menu

This article has a correction. Please see:

PDF
Clinical and epidemiological research
Extended report
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis

Authors

  • Jackie L Nam Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Sofia Ramiro Academic Medical Center, University of Amsterdam, Amsterdam, and Hospital Garcia de Orta, Almada, Portugal PubMed articlesGoogle scholar articles
  • Cecile Gaujoux-Viala Department of Rheumatology, Nîmes University Hospital, Montpellier I University, Nimes, France PubMed articlesGoogle scholar articles
  • Kaoru Takase Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK Department of Internal Medicine and Clinical Immunology, Graduate School of Medicine and Faculty of Medicine, Yokohama City University, Yokohama, Japan PubMed articlesGoogle scholar articles
  • Mario Leon-Garcia Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK R4 de Reumatologia del Hospital de Valme, Seville, Spain PubMed articlesGoogle scholar articles
  • Paul Emery Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  • Laure Gossec Rheumatology Department, Paris 06 UPMC University, AP-HP, Pite-Salpetriere Hospital, Paris, France PubMed articlesGoogle scholar articles
  • Robert Landewe Academic Medical Center, University of Amsterdam, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands PubMed articlesGoogle scholar articles
  • Josef S Smolen Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria 2nd Department of Medicine, Hietzing Hospital Vienna, Vienna, Austria PubMed articlesGoogle scholar articles
  • Maya H Buch Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Maya H Buch, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK; M.Buch{at}leeds.ac.uk
View Full Text

Citation

Nam JL, Ramiro S, Gaujoux-Viala C, et al
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
Annals of the Rheumatic Diseases 2014;73:516-528.

Publication history

  • Received September 8, 2013
  • Revised October 15, 2013
  • Accepted October 24, 2013
  • First published January 7, 2014.
Online issue publication 
February 04, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions